Neutral impactStocks
Buy, Sell or Hold? Goldman Sachs maintains a buy on Eternal; Citi recommends sell rating on Dr Reddy’s Laboratories post Q1 results
Economic Times 1 hr ago·23 Jul 2026, 5:15 am
Goldman Sachs and Citi have issued fresh post-Q1 calls on three stocks. Goldman stays bullish on Eternal (Buy, target Rs 345, 21% upside) due to Blinkit's margin gains. Citi holds a Buy on JSW Energy (target Rs 650) despite EBITDA missing estimates, but maintains a Sell on Dr Reddy's, cutting the target to Rs 1,040 after a 69% profit fall.
Affected stocks
Neutral1 stock
Bull / bear label is derived from the article's AI sentiment — indicative, not advice. Prices may be delayed.
Key takeaways
- Concerns DR. Reddy S Laboratories (DRREDDY).
- Category: Stocks.
Why it matters
A routine update for DR. Reddy S Laboratories. Use the price and stock snapshot to gauge how the market is responding.
